APA (7th ed.) Citation

Reinisch, W., Colombel, J., D'Haens, G. R., Rimola, J., Masior, T., McKevitt, M., . . . Gecse, K. B. (2024). Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial. Journal of Crohn's & Colitis, 18(6), 864. https://doi.org/10.1093/ecco-jcc/jjae003

Chicago Style (17th ed.) Citation

Reinisch, Walter, et al. "Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial." Journal of Crohn's & Colitis 18, no. 6 (2024): 864. https://doi.org/10.1093/ecco-jcc/jjae003.

MLA (9th ed.) Citation

Reinisch, Walter, et al. "Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial." Journal of Crohn's & Colitis, vol. 18, no. 6, 2024, p. 864, https://doi.org/10.1093/ecco-jcc/jjae003.